Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Yield and Water Quality Impacts of Field-Scale Integration of Willow into a Continuous Corn Rotation System.

Zumpf C, Ssegane H, Negri MC, Campbell P, Cacho J.

J Environ Qual. 2017 Jul;46(4):811-818. doi: 10.2134/jeq2017.02.0082.

PMID:
28783783
2.

Differential Functional Constraints Cause Strain-Level Endemism in Polynucleobacter Populations.

Sangwan N, Zarraonaindia I, Hampton-Marcell JT, Ssegane H, Eshoo TW, Rijal G, Negri MC, Gilbert JA.

mSystems. 2016 May 24;1(3). pii: e00003-16. eCollection 2016 May-Jun.

3.
4.

Modifications of the cell wall of yeasts grown on hexadecane and under starvation conditions.

Dmitriev VV, Crowley DE, Zvonarev AN, Rusakova TG, Negri MC, Kolesnikova SA.

Yeast. 2016 Feb;33(2):55-62. doi: 10.1002/yea.3140. Epub 2015 Dec 1.

5.

Achieving the Great Lakes Initiative mercury limits in oil refinery effluent.

Urgun-Demirtas M, Gillenwater P, Negri MC, Lin Y, Snyder S, Doctor R, Pierce L, Alvarado J.

Water Environ Res. 2013 Jan;85(1):77-86.

PMID:
23409456
6.

Meeting world's most stringent Hg criterion: a pilot-study for the treatment of oil refinery wastewater using an ultrafiltration membrane process.

Urgun-Demirtas M, Negri MC, Gillenwater PS, Nnanna AG, Yu J.

J Environ Manage. 2013 Mar 15;117:65-75. doi: 10.1016/j.jenvman.2012.12.011. Epub 2013 Jan 24.

PMID:
23353879
7.

Achieving very low mercury levels in refinery wastewater by membrane filtration.

Urgun-Demirtas M, Benda PL, Gillenwater PS, Negri MC, Xiong H, Snyder SW.

J Hazard Mater. 2012 May 15;215-216:98-107. doi: 10.1016/j.jhazmat.2012.02.040. Epub 2012 Feb 22.

PMID:
22410725
8.

Comparative evaluation of As, Se and V removal technologies for the treatment of oil refinery wastewater.

Gillenwater PS, Urgun-Demirtas M, Negri MC, Snyder SW.

Water Sci Technol. 2012;65(1):112-8. doi: 10.2166/wst.2011.842.

PMID:
22173414
9.

Improving data quality on low level mercury wastewater analysis.

Gillenwater PS, Urgun-Demirtas M, Negri MC, Alvarado J.

J Environ Monit. 2012 Jan;14(1):27-9. doi: 10.1039/c1em10710k. Epub 2011 Nov 10.

PMID:
22076073
10.

An attempt towards simultaneous biobased solvent based extraction of proteins and enzymatic saccharification of cellulosic materials from distiller's grains and solubles.

Datta S, Bals BD, Lin YJ, Negri MC, Datta R, Pasieta L, Ahmad SF, Moradia AA, Dale BE, Snyder SW.

Bioresour Technol. 2010 Jul;101(14):5444-8. doi: 10.1016/j.biortech.2010.02.039. Epub 2010 Mar 4.

PMID:
20206501
11.

Biofuels, land, and water: a systems approach to sustainability.

Gopalakrishnan G, Negri MC, Wang M, Wu M, Snyder SW, Lafreniere L.

Environ Sci Technol. 2009 Aug 1;43(15):6094-100.

PMID:
19731724
12.

Mass recovery methods for trichloroethylene in plant tissue.

Gopalakrishnan G, Werth CJ, Negri MC.

Environ Toxicol Chem. 2009 Jun;28(6):1185-90. doi: 10.1897/08-420.1.

PMID:
19159128
13.

Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation.

Morosini MI, Baquero MR, Sánchez-Romero JM, Negri MC, Galán JC, del Campo R, Pérez-Díaz JC, Baquero F.

Antimicrob Agents Chemother. 2003 Apr;47(4):1464-7. Erratum in: Antimicrob Agents Chemother. 2003 Jun;47(6):2064.

14.
16.

Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations.

Negri MC, Morosini MI, Baquero MR, del Campo R, Blázquez J, Baquero F.

Antimicrob Agents Chemother. 2002 Feb;46(2):528-30.

17.

In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.

Morosini MI, Cantón R, Loza E, Negri MC, Galán JC, Almaraz F, Baquero F.

Antimicrob Agents Chemother. 2001 Sep;45(9):2427-31.

18.

Antibiotic resistance in hospital infections: the role of newer cephalosporins.

Negri MC, Morosini MI, Blázquez J, Baquero F.

Clin Microbiol Infect. 2000;6 Suppl 3:95-7. Review. No abstract available.

19.

Perspectives of oral cephalosporins in upper respiratory tract infections.

Negri MC, Morosini MI, Loza E, Baquero F.

Clin Microbiol Infect. 2000;6 Suppl 3:56-8. Review. No abstract available.

20.

Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase.

Tondi D, Powers RA, Caselli E, Negri MC, Blázquez J, Costi MP, Shoichet BK.

Chem Biol. 2001 Jun;8(6):593-611.

21.

Selection of very small differences in bacterial evolution.

Baquero F, Negri MC, Morosini MI, Blázquez J.

Int Microbiol. 1998 Dec;1(4):295-300. Review.

PMID:
10943377
22.

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance.

Negri MC, Lipsitch M, Blázquez J, Levin BR, Baquero F.

Antimicrob Agents Chemother. 2000 Sep;44(9):2485-91.

23.

[National multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens. Spanish Study Group on Moxifloxacin].

Loza E, Morosini M, Negri MC, Almaraz F, Cantón R, Baquero F.

Rev Esp Quimioter. 2000 Mar;13(1):37-43. Spanish.

PMID:
10855023
24.

Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.

Blazquez J, Morosini MI, Negri MC, Baquero F.

Antimicrob Agents Chemother. 2000 Aug;44(8):2182-4.

25.

[National Multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens]

Loza E, Morosini M, Negri MC, Almaraz F, Cantón R, Baquero F.

Rev Esp Quimioter. 2000 Mar;13(1):37-43. Spanish.

PMID:
10878536
26.

Selective removal of plutonium 238 from a canal sediment using a carbonate-chelant soil washing technology (ACT*DE*CON).

Negri MC, Swift NA, Carfagno D, Neff RA, North J.

J Hazard Mater. 1999 Apr 23;66(1-2):99-118.

PMID:
10379033
27.

An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection.

Morosini MI, Negri MC, Shoichet B, Baquero MR, Baquero F, Blázquez J.

FEMS Microbiol Lett. 1998 Aug 1;165(1):85-90.

28.

Antibiotic-selective environments.

Baquero F, Negri MC, Morosini MI, Blázquez J.

Clin Infect Dis. 1998 Aug;27 Suppl 1:S5-11. Review.

PMID:
9710666
29.

A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.

Blázquez J, Negri MC, Morosini MI, Gómez-Gómez JM, Baquero F.

Antimicrob Agents Chemother. 1998 May;42(5):1042-4.

30.

[Meropenem against bacteria carriers of wide spectrum TEM beta-lactamases: evolutive aspects].

Baquero F, Morosini MI, Negri MC, Cantón R, Blázquez J.

Enferm Infecc Microbiol Clin. 1997 Sep;15 Suppl 1:27-31. Spanish.

PMID:
9410066
31.

Selective compartments for resistant microorganisms in antibiotic gradients.

Baquero F, Negri MC.

Bioessays. 1997 Aug;19(8):731-6. Review.

PMID:
9264256
32.

Strategies to minimize the development of antibiotic resistance.

Baquero F, Negri MC.

J Chemother. 1997 May;9 Suppl 3:29-37. Review.

PMID:
9248978
33.

The antibiotic selective process: concentration-specific amplification of low-level resistant populations.

Baquero F, Negri MC, Morosini MI, Blázquez J.

Ciba Found Symp. 1997;207:93-105; discussion 105-11. Review.

PMID:
9189637
34.

Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen.

Morosini MI, Blázquez J, Negri MC, Cantón R, Loza E, Baquero F.

J Infect Dis. 1996 Nov;174(5):1015-20.

PMID:
8896503
35.

New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak.

Morosini MI, Canton R, Martinez-Beltran J, Negri MC, Perez-Diaz JC, Baquero F, Blazquez J.

Antimicrob Agents Chemother. 1995 Feb;39(2):458-61.

36.

Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.

Blazquez J, Morosini MI, Negri MC, Gonzalez-Leiza M, Baquero F.

Antimicrob Agents Chemother. 1995 Jan;39(1):145-9.

37.

In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.

Negri MC, Morosini MI, Loza E, Baquero F.

Antimicrob Agents Chemother. 1994 Jan;38(1):122-5.

38.

In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in Argentina.

Casellas JM, Goldberg M, Orellana N, Morosini MI, Negri MC, Arduino S.

Infection. 1990 May-Jun;18(3):193-5.

PMID:
2114372

Supplemental Content

Loading ...
Support Center